Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology • Bone Marrow Transplant • Anemia • Hematology • Bone Marrow Failure • Benign Hematology
How do you decide between HSCT and immunosuppressive therapy for treating hepatitis associated aplastic anemia?
Answer from: at Academic Institution
For young people with a donor, the primary therapy is transplantation. It is curative in the vast majority of patients, hepatitis-associated AA is much less likely to respond to immunotherapy.
Sign in or Register to read more